Table 1.
Con/PBS | Ob/PBS | Ob/ADN | P(ANOVA) | |
---|---|---|---|---|
Male offspring | n = 7 | n = 7 | n = 9 | |
Left ventricle | ||||
Anterior wall (diastole), mm | 0.52 ± 0.01 | 0.51 ± 0.01 | 0.50 ± 0.01 | 0.34 |
Anterior wall (systole), mm | 0.73 ± 0.01 | 0.71 ± 0.01 | 0.71 ± 0.01 | 0.43 |
Posterior wall (diastole), mm | 0.52 ± 0.01 | 0.50 ± 0.01 | 0.50 ± 0.01 | 0.37 |
Posterior wall (systole), mm | 0.73 ± 0.01 | 0.71 ± 0.01 | 0.71 ± 0.01 | 0.31 |
Internal volume (diastole), μl | 57.3 ± 2.8 | 66.6 ± 3.1 | 64.1 ± 3.1 | 0.12 |
Internal volume (systole), μl | 21.9 ± 2.0 | 25.6 ± 2.4 | 23.1 ± 1.9 | 0.49 |
Ejection fraction (%) | 62.2 ± 1.8 | 62.0 ± 1.8 | 64.3 ± 1.8 | 0.61 |
Fractional shortening (%) | 33.0 ± 1.2 | 33.0 ± 1.2 | 34.7 ± 1.4 | 0.56 |
Heart rate, bpm | 502 ± 14 | 504 ± 12 | 532 ± 11 | 0.15 |
Female offspring | n = 10 | n = 6 | n = 8 | |
Left ventricle | ||||
Anterior wall (diastole), mm | 0.51 ± 0.01 | 0.49 ± 0.01 | 0.48 ± 0.01 | 0.26 |
Anterior wall (systole), mm | 0.71 ± 0.02 | 0.69 ± 0.01 | 0.69 ± 0.02 | 0.53 |
Posterior wall (diastole), mm | 0.50 ± 0.01 | 0.48 ± 0.01 | 0.48 ± 0.01 | 0.25 |
Posterior wall (systole), mm | 0.71 ± 0.01 | 0.69 ± 0.01 | 0.69 ± 0.02 | 0.45 |
Internal volume (diastole), μl | 50.3 ± 2.1a | 62.6 ± 2.7b | 55.6 ± 3.4ab | 0.02 |
Internal volume (systole), μl | 18.8 ± 0.9 | 23.5 ± 2.3 | 19.7 ± 1.5 | 0.10 |
Ejection fraction (%) | 62.6 ± 1.1 | 62.8 ± 2.1 | 64.6 ± 1.5 | 0.59 |
Fractional shortening (%) | 33.1 ± 0.8 | 33.4 ± 1.4 | 34.6 ± 1.1 | 0.54 |
Heart rate, bpm | 542 ± 13 | 521 ± 15 | 529 ± 6 | 0.44 |
Mean ± SEM echocardiographic measurements of left ventricular morphology and systolic function and heart rate in 3-month-old offspring of control, PBS-infused pregnant mice and obese pregnant mice infused either with PBS or adiponectin from E14.5 to 18.5. Values in bold indicate significant overall effect of maternal treatment group by one-way ANOVA. Values with different superscripts, a or b, are significantly different from one another by pairwise post hoc comparison (P < 0.05, Holm–Sidak test)
ADN adiponectin, ANOVA analysis of variance, Con control, Ob obese, PBS phosphate-buffered saline